Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice

Life Sciences

Volumn 62, Issue 16, 1998, Pages 1371-1378

  Thongpradichote, Suchitra ^a   Matsumoto, Kinzo ^a   Tohda, Michihisa ^a   Takayama, Hiromitsu ^b   Aimi, Norio ^b   Sakai, Shin Ichiro ^b   Watanabe, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Antinociception; Mice; Mitragynine; Opioid receptor subtype

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ALKALOID; CYPRODIME; KAPPA OPIATE RECEPTOR; MITRAGYNINE; MORPHINE; MU OPIATE RECEPTOR; NALOXONAZINE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN;

ANALGESICS; ANIMALS; DRUG SYNERGISM; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NOCICEPTORS; PAIN MEASUREMENT; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; SECOLOGANIN TRYPTAMINE ALKALOIDS;

ANIMALIA; MITRAGYNA SPECIOSA;

EID: 0032513107     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00075-7     Document Type: Article

References (37)

1. 1. D. PONGLUX, S. WONGSERIPIPATANA, H. TAKAYAMA, M. KIKUCHI, M. KURIHARA, M. KITAJIMA, N. AIMI and S.-I. SAKAI, Planta Med. 60 580-581 (1994).
2. 2. E. J. SHELLARD, Bulletin on Narcotics 26 41-55 (1974).
3. 3. K. L. R. JANSEN and C. J. PRAST, J. Ethnopharmacol. 23 115-119 (1988).
4. 4. K. MATSUMOTO, M. MIZOWAKI, S. THONGPRADITCHOTE, H. TAKAYAMA, S.-I. SAKAI, N. AIMI and H. WATANABE, Life Sci. 59 1149-1155 (1996).
5. 5. K. MATSUMOTO, M. MIZOWAKI, S. THONGPRADITCHOTE, Y. MURAKAMI, H. TAKAYAMA, S.-I. SAKAI, N. AIMI and H. WATANABE, Eur. J. Pharmacol. 371 75-81 (1996).
6. 6. M. NARITA, K. TAKAHASHI, K. TAKAMORI, M. FUNADA, T. SUZUKI, M. MISAWA and H. NAGASE, Jpn. J. Pharmacol. 62 15-24 (1993).
7. 7. S. J. WARD and A. E. TAKEMORI, J. Pharmacol. Exp. Ther. 224 525-530 (1983).
8. 8. T. L. YAKSH, Acta Anaes. Scand. 14 94-111 (1997).
9. 9. G. S. F. LING and G. W. PASTERNAK, Brain Res. 271 152-156 (1983).
10. 10. H. SCHMIDHAMMER, W. P. BURKARD, L. EGGSTEIN-AEPPLI and C. F. C. SMITH, J. Med. Chem. 32 418-421 (1989).
11. 11. E. F. HAHN, S. NISHIMURA, R. R. GOODMAN and G. W. PASTERNAK, J. Pharmacol. Exp. Ther. 235 839-845 (1985).
12. 12. P. S. PORTOGHESE, M. SULTANA and A. E. TAKEMORI, Eur. J. Pharmacol. 146 185-186 (1988).
13. 13. P. S. PORTOGHESE, A. W. LIPKOWSKI and A. E. TAKEMORI, Life Sci. 40 1287-1292 (1987).
14. 14. A. E. TAKEMORI, B. Y. HO, J. S. NAESETH and P. S. PORTOGHESE, J. Pharmacol. Exp. Ther. 246 255-258 (1988).
15. 15. H. TAKAGI, T. INUKAI and M. NAKAMA, Jpn. J. Pharmacol. 16 287-294 (1966).
16. 16. N. B. EDDY and D. LEIMBACH, J. Pharmacol. Exp. Ther. 107 385-389 (1953).
17. 17. S. HUNSKARR, O.-G. BERGE and K. HOLE, Behav. Brain Res. 21 101-108 (1986).
18. 18. A. B. MALMBERG and T. L. YAKSH, J. Pharmacol. Exp. Ther. 263 264-275 (1992).
19. 19. C. G. PICK, D. PAUL and G. W. PASTERNAK, Life Sci. 48 2005-2011 (1991).
20. 20. M. NARITA, T. TAKAHASHI, K. TAKAMORI, M. FUNADA, T. SUZUKI, M. MISAWA and H. NAGASE, Jpn. J. Pharmacol. 62 15-24 (1993).
21. 21. T. J. HALEY and W. G. MCCORMICK, Br. J. Pharmacol. 12 12-15 (1957).
22. 22. S. C. ROERIG and J. M. FUJIMOTO, J. Pharmacol. Exp. Ther. 249 762-768 (1989).
23. 23. I. SORA, N. TAKAHASHI, M. FUNADA, H. UJIKE, R. S. REVAY, D. M. DONOVAN, L. L. MINER and G. R. UHL, Proc. Natl. Acad. Sci. 94 1544-1549 (1997).
24. 24. M. B. TYERS, Br. J. Pharmacol. 69 503-512 (1980).
25. 25. A. S. MOSKOWITZ and R. R. GOODMAN, Brain Res. 360 117-129 (1985).
26. 26. G. W. PASTERNAK and P. J. WOOD, Life Sci. 38 1889-1898 (1986).
27. 27. D. PAUL, R. J. BODNAR, M. A. GISTRAK and G. W. PASTERNAK, Eur J Pharmacol. 168 307-314 (1989).
28. 28. C. G. PICK, D. PAUL and G. W. PASTERNAK, Life Sci. 48 2005-2011 (1991).
29. 29. R. J. BODNAR, C. L. WILLIAMS, S. J. LEE and G. W. PASTERNAK, Brain Res. 447 25-34 (1988).
30. 30. C. D. CONNELLY, R. P. MARTINEZ, J. J. SCHUPSKY, F. PORRECA and R. B. RAFFA, Life Sci. 54 369-374 (1994).
31. 31. J. R. TRAYNOR, J. C. HUNTER, R. E. RODRIGUEZ, R. G. HILL and J. HUGHES, Br. J. Pharmacol. 100 319-323 (1990).
32. 32. M. TOHDA, S. THONGPRADITCHOTE, K. MATSUMOTO, H. TAKAYAMA, S.-I. SAKAI, N. AIMI and H. WATANABE, Biol. Pharm. Bull. 20 338-340 (1997).
33. 33. S. F. ATWEH and M. J. KUHAR, Br. Med. Bull. 39 47-52 (1983).
34. 34. T. L. YAKSH and R. NOUEIHED, Ann. Rev. Pharmacol. Toxicol. 25 433-462 (1985).
35. 35. P. F. VONVOIGTLANDER, R. A. LEWIS and G. L. NEFF, J. Pharmacol. Exp. Ther. 231 270-274 (1984).
36. 36. B. Y. HO and A. E. TAKEMORI, J. Pharmacol. Exp. Ther. 250 508-512 (1989).
37. 37. B. Y. HO and A. E. TAKEMORI, J. Pharmacol. Exp. Ther. 254 8-12 (1990).